LifeTech Scientific Corporation (HKG:1302)
Hong Kong · Delayed Price · Currency is HKD 1.950
-0.050 (-2.50%)
May 11, 2026, 4:08 PM HKT
LifeTech Scientific Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 147.83 | 222.39 | 263.24 | 325.34 | 292.47 |
Depreciation & Amortization | 102.01 | 86.86 | 75.31 | 66.08 | 61.46 |
Other Amortization | 1.09 | 1.14 | 1.85 | 1.03 | 0.6 |
Loss (Gain) From Sale of Assets | 3.67 | 0.53 | 0.06 | 0.34 | -0.06 |
Asset Writedown & Restructuring Costs | 18.65 | 65.97 | - | 21.31 | - |
Loss (Gain) From Sale of Investments | 12.16 | -38.45 | 177.96 | 35.23 | 51.08 |
Loss (Gain) on Equity Investments | -6.2 | 0.66 | 1.96 | 1.77 | 0.87 |
Stock-Based Compensation | 223.29 | 133.38 | 112.84 | 62.72 | 19.73 |
Provision & Write-off of Bad Debts | -0.71 | 3.04 | -0.85 | 1.91 | -8.51 |
Other Operating Activities | -75.51 | -120.78 | -196.46 | -62.53 | -91.95 |
Change in Accounts Receivable | -4.19 | 31.86 | 98.97 | -18.34 | 56.68 |
Change in Inventory | 81.86 | -61.28 | -248.46 | -112.71 | -31.36 |
Change in Accounts Payable | 8.33 | -2.17 | 119.14 | 94.41 | 114.26 |
Change in Unearned Revenue | 9.81 | 13.68 | 7.16 | 19.38 | 9.78 |
Change in Other Net Operating Assets | 27.2 | -15.37 | 5.34 | -47.61 | -33.95 |
Operating Cash Flow | 549.28 | 321.46 | 418.05 | 388.32 | 441.09 |
Operating Cash Flow Growth | 70.87% | -23.11% | 7.66% | -11.96% | 30.30% |
Capital Expenditures | -68.47 | -196.64 | -200.83 | -226.37 | -275.82 |
Sale of Property, Plant & Equipment | 2.02 | 0.44 | 0.55 | 1.88 | 0.5 |
Cash Acquisitions | -3.28 | -6.77 | - | - | - |
Sale (Purchase) of Intangibles | -1.26 | -8.55 | -91.86 | -109.1 | -67.46 |
Investment in Securities | -14.86 | -261.96 | -190.4 | -161.17 | 127.65 |
Other Investing Activities | -41.54 | -44.06 | 28.65 | 36.3 | 176.14 |
Investing Cash Flow | -127.38 | -517.54 | -453.88 | -458.47 | -39 |
Short-Term Debt Issued | - | 99 | - | - | - |
Long-Term Debt Issued | - | - | - | - | 67.5 |
Total Debt Issued | - | 99 | - | - | 67.5 |
Short-Term Debt Repaid | - | -99 | - | - | - |
Long-Term Debt Repaid | -4.52 | -7.07 | -9.31 | -12.47 | -185.9 |
Total Debt Repaid | -4.52 | -106.07 | -9.31 | -12.47 | -185.9 |
Net Debt Issued (Repaid) | -4.52 | -7.07 | -9.31 | -12.47 | -118.4 |
Issuance of Common Stock | 8.08 | 0.51 | 207.27 | 65.39 | 17.84 |
Repurchase of Common Stock | -397.13 | -146.64 | -26.03 | -268.29 | -170.52 |
Other Financing Activities | 23.79 | 36.24 | 10.78 | 0.16 | 14.7 |
Financing Cash Flow | -369.78 | -116.97 | 182.71 | -215.2 | -256.38 |
Foreign Exchange Rate Adjustments | 1.44 | -0.52 | -1.36 | -0.12 | 1.86 |
Net Cash Flow | 53.56 | -313.56 | 145.52 | -285.47 | 147.58 |
Free Cash Flow | 480.81 | 124.83 | 217.22 | 161.95 | 165.27 |
Free Cash Flow Growth | 285.19% | -42.54% | 34.13% | -2.01% | -29.21% |
Free Cash Flow Margin | 35.10% | 9.57% | 17.14% | 14.76% | 17.86% |
Free Cash Flow Per Share | 0.11 | 0.03 | 0.05 | 0.04 | 0.04 |
Cash Interest Paid | 0.21 | 1.89 | 0.72 | 0.63 | 2.61 |
Cash Income Tax Paid | 93.16 | 78.35 | 80.41 | 71.11 | 59.68 |
Levered Free Cash Flow | 1,020 | 93.63 | -202.65 | -68.71 | 165.52 |
Unlevered Free Cash Flow | 1,020 | 94.81 | -202.2 | -68.31 | 167.15 |
Change in Working Capital | 123.02 | -33.27 | -17.86 | -64.87 | 115.41 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.